MedTrace Logo

SurmodiCs Pounce Venous THrOMbectomy System Post Market Clinical Follow Up Study

NCT05600816 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-05-08

No results posted yet for this study

Summary

This is an open label, prospective, non-randomised, multi-centre post market study of the POUNCE Venous Thrombectomy system for de-clotting in the peripheral vasculature (e.g., iliofemoral veins).

Conditions

  • Peripheral Vascular Occlusive Disease

Interventions

DEVICE

Pounce Venous Thrombectomy System

The device is indicated for mechanical de-clotting and controlled and selective infusion of physician specified fluids, including thrombolytics, in the peripheral vasculature.

Sponsors & Collaborators

  • SurModics, Inc.

    lead INDUSTRY

Principal Investigators

  • Michael Lichtenberg, MD · Klinikum Hochsauerland GmbH

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2025-10-01
Completion
2026-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05600816 on ClinicalTrials.gov